Antineoplastic agent
Monoclonal antibody-containing product
|
|
Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)
Monoclonal antibody antineoplastic agent
Id
1144210000
Status
Defined
Plays role
Antineoplastic therapeutic role
Has active ingredient
monoklonaal antilichaam
|
Alemtuzumab-containing product
2
Amivantamab-containing product
2
Atezolizumab-containing product
2
Avelumab-containing product
2
Belantamab mafodotin-containing product
2
Bevacizumab-containing product
2
Blinatumomab-containing product
2
Brentuximab vedotin-containing product
2
Cemiplimab-containing product
2
Cetuximab-containing product
2
Daratumumab-containing product
2
Dinutuximab-containing product
2
Dostarlimab-containing product
2
Durvalumab-containing product
2
Elotuzumab-containing product
2
Enfortumab vedotin-containing product
2
Gemtuzumab ozogamicin-containing product
2
Ibritumomab tiuxetan-containing product
1
Inotuzumab ozogamicin-containing product
2
Ipilimumab-containing product
2
Isatuximab-containing product
2
Loncastuximab tesirine-containing product
2
Margetuximab-containing product
2
Mogamulizumab-containing product
2
Moxetumomab pasudotox-containing product
2
Naptumomab-containing product
1
Naxitamab-containing product
2
Necitumumab-containing product
2
Nivolumab-containing product
2
Obinutuzumab-containing product
2
Ofatumumab-containing product
2
Olaratumab-containing product
2
Oregovomab-containing product
1
Panitumumab-containing product
2
Pembrolizumab-containing product
2
Pertuzumab-containing product
2
Polatuzumab vedotin-containing product
2
Ramucirumab-containing product
2
Rituximab-containing product
2
Sacituzumab govitecan-containing product
2
Tafasitamab-containing product
2
Tositumomab-containing product
1
Trastuzumab deruxtecan-containing product
2
Trastuzumab emtansine-containing product
2
Trastuzumab-containing product
2
Zanolimumab-containing product
1
